{"id":"https://openalex.org/W31592908","doi":null,"title":"Calanolides, the naturally occurring anti-HIV agents.","display_name":"Calanolides, the naturally occurring anti-HIV agents.","publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W31592908","mag":"31592908","pmid":"https://pubmed.ncbi.nlm.nih.gov/19649847"},"language":"en","primary_location":{"id":"pmid:19649847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19649847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061188952","display_name":"Zhenghu Xu","orcid":"https://orcid.org/0000-0002-3189-0777","observed_orcids":["https://orcid.org/0000-0002-3189-0777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Q Xu","raw_affiliation_strings":["Sarawak MediChem Pharmaceuticals Inc, Lemont, IL 60439, USA. ZXu@mcr.medichem.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarawak MediChem Pharmaceuticals Inc, Lemont, IL 60439, USA. ZXu@mcr.medichem.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007750929","display_name":"Michael T. Flavin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M T Flavin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013946357","display_name":"Tuah R.\u2010J. Jenta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T R Jenta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4982,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.64548621,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"3","issue":"2","first_page":"155","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13185","display_name":"Phytochemistry and Bioactive Compounds","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calanolide-a","display_name":"calanolide A","score":0.890999972820282},{"id":"https://openalex.org/keywords/hiv-1-reverse-transcriptase-inhibitors","display_name":"HIV-1 reverse transcriptase inhibitors","score":0.8149999976158142},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/y181c-mutation","display_name":"Y181C mutation","score":0.875},{"id":"https://openalex.org/keywords/azt-resistance","display_name":"AZT resistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mixed-inhibition","display_name":"mixed-type inhibition","score":0.7739999890327454},{"id":"https://openalex.org/keywords/enzyme-binding-sites","display_name":"enzyme binding sites","score":0.6330000162124634},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.7873170375823975},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.7017555832862854},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.6142274737358093},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.572222113609314},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5461515188217163},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.524903416633606},{"id":"https://openalex.org/C40479148","wikidata":"https://www.wikidata.org/wiki/Q844460","display_name":"Syncytium","level":3,"score":0.5239817500114441},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5195974707603455},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35006284713745117},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2045365571975708},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.17564216256141663},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1275193989276886},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.07757014036178589},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.06616681814193726}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:19649847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19649847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},{"id":"mag:31592908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19649847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W78186734","https://openalex.org/W1862237385","https://openalex.org/W1974601142","https://openalex.org/W2014140858","https://openalex.org/W2025243746","https://openalex.org/W2035123752","https://openalex.org/W2041141449","https://openalex.org/W2042814728","https://openalex.org/W2049686095","https://openalex.org/W2108888253","https://openalex.org/W2109777848","https://openalex.org/W2118476803","https://openalex.org/W2139853056","https://openalex.org/W2255404396","https://openalex.org/W2394631798","https://openalex.org/W2395395500","https://openalex.org/W2466888597","https://openalex.org/W2528161171","https://openalex.org/W2562550784","https://openalex.org/W2770510181","https://openalex.org/W2772784997","https://openalex.org/W2774658967","https://openalex.org/W2920216614","https://openalex.org/W2923349948","https://openalex.org/W2926182388","https://openalex.org/W2928842550","https://openalex.org/W2945916009","https://openalex.org/W6761413876"],"related_works":["https://openalex.org/W1513226879","https://openalex.org/W2437191410","https://openalex.org/W2312425642","https://openalex.org/W1897046565","https://openalex.org/W2274802105","https://openalex.org/W7100101490","https://openalex.org/W2159935163","https://openalex.org/W2014531371","https://openalex.org/W2231831983","https://openalex.org/W3096534146"],"abstract_inverted_index":{"Both":[0],"naturally":[1],"occurring":[2],"and":[3,43,47,49,109,130,174,207,247,254,286,314],"semi-synthetic":[4],"calanolide":[5,113,136,242,258,274,306],"compounds":[6,53,114,243],"are":[7,19,120,168,179],"potent":[8,301],"anti-human":[9],"immunodeficiency":[10],"virus":[11,27],"(HIV)":[12],"agents.":[13,186],"In":[14,132],"fresh":[15],"human":[16],"cells,":[17],"they":[18],"highly":[20,121],"effective":[21],"inhibitors":[22],"against":[23,60],"low":[24],"passage":[25],"clinical":[26,310],"strains,":[28],"including":[29],"those":[30],"representative":[31],"of":[32,62,87,220,250,256,273,278,305],"the":[33,63,76,95,146,201,208,229,241,251,271,276,288,292,299,303],"various":[34],"HIV-1":[35,193,230],"clade":[36],"strains":[37],"(A":[38],"through":[39,195],"F),":[40],"syncytium-inducing":[41],"(SI)":[42],"non-syncytium-inducing":[44],"(NSI)":[45],"isolates,":[46],"T-tropic":[48],"monocyte-tropic":[50],"isolates.":[51],"These":[52,117],"also":[54],"exhibit":[55],"an":[56],"enhanced":[57],"antiviral":[58],"activity":[59,88],"one":[61],"most":[64,300],"prevalent":[65],"non-nucleoside":[66],"reverse":[67,82],"transcriptase":[68,83],"inhibitor":[69],"(NNRTI)-resistant":[70],"viruses":[71,106,144],"that":[72,93,190,198,219],"is":[73,89,216,270,308],"engendered":[74],"by":[75],"Y181C":[77,96,108,289],"amino":[78,148],"acid":[79,149],"change":[80,97],"in":[81,170,181,211,259,275,302,316],"(RT).":[84],"Further":[85],"enhancement":[86],"observed":[90,169],"with":[91,99,105,183],"RTs":[92],"possess":[94],"together":[98],"AZT-resistant":[100],"mutations.":[101,295],"Moreover,":[102],"when":[103,177],"challenged":[104],"containing":[107],"K103N":[110],"dual":[111,118,294],"mutations,":[112],"remain":[115],"active.":[116],"mutations":[119],"resistant":[122,143],"to":[123,154,157,163],"all":[124],"approved":[125],"NNRTIs":[126],"(eg,":[127],"delavirdine,":[128],"nevirapine":[129],"efavirenz).":[131],"cell":[133],"culture":[134],"assays,":[135],"compounds,":[137,307],"especially":[138],"(+)-calanolide":[139,237,297],"A,":[140,298],"select":[141],"primarily":[142],"possessing":[145],"T139I":[147],"change.":[150],"This":[151],"mutation":[152,290],"appears":[153],"be":[155,264],"unique":[156],"calanolides":[158,178,191],"since":[159],"it":[160],"remains":[161],"susceptible":[162],"other":[164,184,221,283],"NNRTIs.":[165,223],"Synergistic":[166],"effects":[167],"both":[171,200],"cultured":[172],"cells":[173],"animal":[175],"models":[176],"used":[180],"combination":[182,261],"anti-HIV":[185],"Enzymatic":[187],"analyses":[188],"indicate":[189],"inhibit":[192],"RT":[194,231],"a":[196,212,245,257,260],"mechanism":[197],"affects":[199],"Km":[202],"for":[203,236,312],"normal":[204],"substrate":[205],"dTTP":[206],"Vmax,":[209],"resulting":[210],"mixed-type":[213],"inhibition,":[214],"which":[215],"different":[217],"from":[218],"known":[222],"Two":[224],"possible":[225],"binding":[226],"modes/sites":[227],"at":[228],"enzyme":[232],"have":[233,281],"been":[234],"suggested":[235],"A.":[238],"Taken":[239],"together,":[240],"represent":[244],"novel":[246],"distinct":[248],"subgroup":[249],"NNRTI":[252,284],"family":[253],"inclusion":[255],"therapy":[262,285],"may":[263],"clinically":[265],"beneficial.":[266],"Of":[267],"particular":[268],"interest":[269],"use":[272],"treatment":[277],"patients":[279],"who":[280],"failed":[282],"developed":[287],"or":[291],"Y181C/K103N":[293],"Currently,":[296],"series":[304],"undergoing":[309],"investigation":[311],"safety":[313],"efficacy":[315],"HIV-infected":[317],"individuals.":[318]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}